Johnson & Johnson (JNJ)

Johnson & Johnson secures FDA clearance for MONARCH QUEST 3 software, boosting robotic bronchoscopy accuracy with AI. new 3D imaging tools.

While investors treat Wall Street like a casino, stick to these Buffett-style "wonderful investments."

The space company is popular right now, but these other corporations look more attractive.

Whether a recession is coming in 2026 or five years from now, the best investors are always figuring out how to prepare.

The pharmaceutical giant just increased its dividend by 3.1%, now paying $5.36 a share annually.

These stocks can help you withstand (almost) any storm.

Amazon, Microsoft, JPMorgan Chase, Johnson & Johnson and Coca-Cola posted strong earnings beats that held up, with cloud growth, capital returns and raised guidance fueling sustained stock gains.

VYM, VCIT, and AGG offer low-cost ETF options for income investors, combining dividend yields between 2.20% and 4.86% with broad diversification and expense ratios as low as 0.03%.

The pharmaceutical icon's dividend yield has been pared back by the stock's recent rally, driven by a new growth initiative.

They are going through a rough patch, but it's too early to give up on them.

Intuitive Surgical is a leader in the surgical robotics space, with a large installed base and strong recurring revenues.

XLV's concentrated 60-stock portfolio beat VHT's broader 423 holdings over five years, though VHT delivered stronger 1-year returns.

Solventum shares gain on strong Q2 revenue, earnings, and cash flow, buybacks, and improved guidance, with analysts raising price targets amid a discounted valuation versus med/tech peers.

These healthcare giants can deliver steady gains.

Investors may want to brace for turbulence. But these stocks should hold up well.